We are developing immunotherapies based on cutting-edge Toll-like receptor (TLR) biology and its ability to modulate the immune system. Learn More >
Through our expertise in TLR biology we are developing compounds designed to stimulate multiple innate mechanisms of tumor killing and development of immune memory associated with tumor-specific antigens. Learn More >
Utilizing Toll-like Receptor biology to leverage the power of the body's immune response to stimulate multiple innate mechanisms, activating a cascade of anti-tumor activities.